McNeil's OTC recalls roll on
This article was originally published in The Tan Sheet
Executive Summary
The Johnson & Johnson subsidiary announces July 8 its fourth recall of products in packaging potentially contaminated with a moldy-smelling chemical. McNeil Consumer Healthcare and FDA announced the recall of 21 lots of drugs - including Tylenol, Benadryl and Motrin stock-keeping units - that originated from the firm's Las Piedras, Puerto Rico, facility and were sold in U.S., Caribbean and other markets. The Las Piedras recalls began in January and, coupled with the recalls of liquid pediatric OTCs from McNeil's Fort Washington, Pa., plant, likely will be discussed at an upcoming follow-up House Oversight and Government Reform Committee hearing (1"The Tan Sheet" June 28, 2010)
You may also be interested in...
Congress Hopes To Land J&J Chief Weldon For Second Recall Inquiry
House members again try to put Johnson & Johnson CEO William Weldon in the hot seat, asking him for the second time since May to testify on OTC quality control issues at J&J's McNeil Consumer Healthcare
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.